Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33712
Title: New anti-obesity medications: Considerations and future directions in people with concurrent eating disorders.
Austin Authors: Sharp, Gemma;Girolamo, Teresa;Hay, Phillipa;Mitchison, Deborah;Cooper, Kelly;Sumithran, Priya ;Jebeile, Hiba
Affiliation: Department of Neuroscience, Monash University, Melbourne, Vic
You Health, Adelaide Weight Management Solutions, Adelaide, SA.
Eating Disorders and Body Image, Translational Health Research Institute, School of Medicine, Western Sydney University, Sydney, NSW; Director Mental Health Research, South West Sydney Local Health District, Sydney, NSW.
Graduate School of Health, University of Technology Sydney, Sydney, NSW; Adjunct Associate Professor, Translational Health Research Institute, School of Medicine, Western Sydney University, Sydney, NSW; Clinical Psychologist, Basten and Associates, Sydney, NSW; Adjunct Fellow, Centre for Emotional Health, Macquarie University, Sydney, NSW.
The Obesity Collective, Sydney, NSW.
Department of Medicine (St Vincent@s), The University of Melbourne, Fitzroy, Vic.
PhD, NHMRC Emerging Leadership Fellow Children@s Hospital at Westmead Clinical School, The University of Sydney, Westmead, NSW.
Alfred Health, Melbourne, Vic.
Endocrinology
Issue Date: Sep-2023
Publication information: Australian Journal of General Practice 2023-09; 52(9)
URI: https://ahro.austin.org.au/austinjspui/handle/1/33712
DOI: 10.31128/AJGP-02-23-6731
ORCID: 
Journal: Australian Journal of General Practice
Start page: 651
End page: 653
PubMed URL: 37666788
ISSN: 2208-7958
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

30
checked on Nov 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.